Drug Information

Drug General Information
Drug ID
D0M2WQ
Former ID
DIB004367
Drug Name
CAP-7.1
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 2 [524688]
Company
CellAct Pharma GmbH
Structure
Download
2D MOL
Target and Pathway
Target(s) DNA topoisomerase II Target Info Modulator [1572591]
References
Ref 524688ClinicalTrials.gov (NCT02094560) CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.